###begin article-title 0
Perforin deficiency attenuates collagen-induced arthritis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 156 158 156 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 462 464 462 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 583 586 583 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 705 708 705 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 725 728 725 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 790 793 790 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 817 820 815 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 914 917 908 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 942 945 934 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 975 977 963 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1108 1112 1096 1100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1134 1138 1122 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
###xml 1069 1075 <span type="species:ncbi:9913">bovine</span>
###xml 1112 1116 <span type="species:ncbi:10090">mice</span>
###xml 1138 1142 <span type="species:ncbi:10090">mice</span>
Collagen-induced arthritis (CIA), an approved animal model for rheumatoid arthritis, is thought to be a T cell-dependent disease. There is evidence that CD8+ T cells are a major subset controlling the pathogenesis of CIA. They probably contribute to certain features of disease, namely tissue destruction and synovial hyperplasia. In this study we examined the role of perforin (pfp), a key molecule of the cytotoxic death pathway that is expressed mainly in CD8+ T cells, for the pathogenesis of CIA. We generated DBA/1J mice suffering from mutations of the pfp molecule, DBA/1J-pfp-/-, and studied their susceptibility to arthritis. As a result, pfp-deficient mice showed a reduced incidence (DBA/1J-pfp+/+, 64%; DBA/1J-pfp-/-, 54%), a slightly delayed onset (onset of disease: DBA/1J-pfp+/+, 53 +/- 3.6; DBA/1J-pfp-/-, 59 +/- 4.9 (mean +/- SEM), and milder form of the disease (maximum disease score: DBA/1J-pfp+/+, 7.3 +/- 1.1; DBA/1J-pfp-/-, 3.4 +/- 1.4 (mean +/- SEM); P < 0.05). Concomitantly, peripheral T cell proliferation in response to the specific antigen bovine collagen II was increased in pfp-/- mice compared with pfp+/+ mice, arguing for an impaired killing of autoreactive T cells caused by pfp deficiency. Thus, pfp-mediated cytotoxicity is involved in the initiation of tissue damage in arthritis, but pfp-independent cytotoxic death pathways might also contribute to CIA.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 712 713 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 714 715 714 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1100 1108 1100 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1112 1114 1112 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1575 1577 1575 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1578 1580 1578 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 154 160 <span type="species:ncbi:9913">bovine</span>
###xml 215 218 <span type="species:ncbi:31658">CFA</span>
Collagen-induced arthritis (CIA) is an experimental model of arthritis inducible in susceptible strains of mice, for example DBA1/J, by immunization with bovine collagen type II (CII) in complete Freund's adjuvant (CFA) [1-4]. The development of CIA is known to depend on T cells, and disease susceptibility is linked to the major histocompatibility complex (MHC) region [5]. After T cell activation an inflammatory cascade involving T cells, macrophages/monocytes, B cells, and activated synoviocytes, is triggered. Different types of leucocytes and synovial cells produce a complex array of cytokines and other soluble mediators, which are thought to be responsible for cartilage destruction and bone erosion [6-9]. Some of the main features of disease are synovial hyperplasia and mononuclear cell infiltration. Factors contributing to this phenomenon are unknown; however, an imbalance between rates of cell proliferation and cell death (apoptosis) has been suggested by recent studies of rheumatoid synovium demonstrating that apoptosis of synovial cells and infiltrating lymphocytes was common in situ [10,11]. In the immune system, apoptosis is involved in development and in the negative selection of lymphocytes. It is also crucial in downregulating immune responses to foreign antigens. Cytotoxic T lymphocytes and other killer cells can eliminate their targets by the induction of cell death. All of these functions are primarily mediated through the receptors Fas/APO-1, tumor necrosis factor receptor 1 (TNFR1; p55 TNFR) and the perforin (pfp)/granzyme pathway [12,13].
###end p 4
###begin p 5
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1061 1063 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
###xml 799 803 <span type="species:ncbi:10090">mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
Perforin is expressed mainly in activated cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells, although some reports suggest its expression in microglia as well [14]. In CTLs, pfp is stored in cytoplasmic granules and is a major effector of cytolysis by these cells. On pfp release it inserts itself into the plasma membrane of target cells and polymerizes into pore forming aggregates. Pores of pfp lead to osmotic lysis of target cells and induce apoptosis by allowing granzymes to enter the target cells. Perforin-deficient mice have confirmed its function as an effector molecule and in the immune response to viruses and tumors as well as in other aspects of immune regulation such as activation-induced cell death (AICD), antibody production and spontaneous autoimmunity [15-17]. NOD mice, an animal model of insulin-dependent diabetes mellitus with a mutation of the pfp gene (NOD/pfp-mice), develop diabetes with highly reduced incidence and markedly delayed onset, pointing to a role of the pfp death pathway in tissue damage in this disease [18].
###end p 5
###begin p 6
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
The role of pfp in arthritis is not clear, although some observations suggest a role in disease pathogenesis, for example pfp-expressing CTLs has been demonstrated in the rheumatoid synovium, and CD8-deficient mice seem to be less susceptible to induction of collagen-induced arthritis [19].
###end p 6
###begin p 7
###xml 367 370 367 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
It is conceivable that the pfp/granzyme pathway could contribute to the pathology of arthritis in at least two ways: promotion of autoimmunity by blocking peripheral tolerance and AICD or destruction of target tissues. In this study we attempted to evaluate the role of the pfp-mediated death pathway in the pathogenesis of CIA with the use of pfp-deficient mice (pfp-/-) by examining the effect of the mutation on the clinical course of disease, immune response to collagen and on joint pathology.
###end p 7
###begin title 8
Materials and methods
###end title 8
###begin title 9
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 9
###begin p 10
###xml 84 88 84 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 472 476 472 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 529 533 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 863 867 <span type="species:ncbi:10090">mice</span>
###xml 1171 1175 <span type="species:ncbi:10090">mice</span>
###xml 1396 1400 <span type="species:ncbi:10090">mice</span>
Perforin-deficient mice were not available on the DBA/1J background. We obtained pfp-/- C57BL/6J (B6) mice, generated as described previously [15], from the Jackson Laboratories (Bar Harbor, ME, USA). These mice were backcrossed onto the CIA-susceptible DBA/1J background (Harlan-Winkelmann, Borchen, Germany) for at least 14 generations. The mice were propagated as hemizygous mutants and the mutations were followed by PCR analysis of tail DNA. To produce homozygous pfp-/- mice for the experiments, heterozygous pfp-deficient mice were intercrossed. Successful backcrossing to the DBA/1J background was assessed by PCR analysis of the MHC-H2 locus [20]. To select mice heterozygous for the pfp-deficiency the primers 5'-TTT TTG AGA CCC TGT AGA CCC A-3' (pfp1) and 5'-GCA TCG CCT TCT ATC GCC TTC T-3' (pfp2) were used. For selection of homozygous pfp-deficient mice, pfp3 primer (5'-CCG GTC CTG AAC TCC TGG CCA A-3') was used in combination with pfp4 primer (5'-CCC CTG CAC ACA TTA CTG GAA G-3'). Microsatellite markers (Metabion GmbH, Planegg-Martinsried, Germany) surrounding the pfp gene were used for determining the size of the C57BL/6J DNA fragment in the mutant mice. The amplified microsatellites were separated and analyzed on denaturing polyacrylamide gels, and were detected with a LI-COR Model 4200L automated DNA sequencer (LI-COR Inc., Lincoln, NE, USA). For the experiments male mice 8 to 16 weeks old were used. Animals were kept and bred under standard conditions at the facility of the University of Rostock. All experiments were approved by the appropriate authorities in the state of Mecklenburg-Vorpommern, Germany.
###end p 10
###begin title 11
Induction and clinical evaluation of collagen-induced arthritis
###end title 11
###begin p 12
###xml 193 219 192 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 86 92 <span type="species:ncbi:9913">bovine</span>
###xml 140 143 <span type="species:ncbi:31658">CFA</span>
###xml 193 219 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 267 270 <span type="species:ncbi:31658">CFA</span>
###xml 277 281 <span type="species:ncbi:10090">Mice</span>
###xml 316 322 <span type="species:ncbi:9913">bovine</span>
###xml 799 802 <span type="species:ncbi:31658">CFA</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
Age-matched mice were immunized intradermally at the base of the tail with 125 mug of bovine CII (Chondrex, Redmond, WA, USA) emulsified in CFA (incomplete Freund's adjuvant containing 4 mg/ml Mycobacterium tuberculosis; Difco Laboratories, Detroit, IL, USA) or with CFA only. Mice were then boosted with 125 mug of bovine CII in incomplete Freund's adjuvant at day 21. Blood were taken at day 0 and day 21 before boosting, and serum was collected. Clinical scores were assessed immediately before immunization (day 0) and thereafter three times weekly. Inflammation of the four paws was scored as follows: 0, no inflammation; 1, swelling or redness of one joint; 2, swelling or redness of more than one joint or mild inflammation of the whole paw; 3, severe inflammation of whole paw or ankylosis. CFA-immunized mice served as controls.
###end p 12
###begin title 13
T cell proliferation response
###end title 13
###begin p 14
###xml 334 336 334 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 834 835 824 825 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 918 919 907 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1017 1018 1006 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:9913">calf</span>
###xml 623 629 <span type="species:ncbi:9913">bovine</span>
Popliteal, preperioteneal, inguinal, mesenterial, axillary and cervical lymph nodes were removed under aseptic conditions. Single-cell suspensions of mononuclear cells of pooled lymph nodes from individual mice were prepared. The cells were cultured in triplicates in flat-bottomed 96-well culture plates, at a concentration of 2 x 106 cells in 200 mul of medium (RPMI 1640 with Glutamax-II supplemented with 50 IU/ml penicillin, 60 mug/ml streptomycin (Gibco, Karlsruhe, Germany) and 5% heat-inactivated fetal calf serum). To investigate the antigen-specific response, lymphocytes were stimulated with 10, 1 or 0.1 mug/ml bovine CII; 4 mug/ml concanavalin A (Difco) was used as positive control, and medium only was used as negative control. Cells were incubated for 72 hours at 37degreesC in a humidified atmosphere containing 5% CO2. To measure the proliferation by DNA synthesis, cells were pulsed with 1 muCi of [3H]thymidine for the last 12 hours of culture. Cells were harvested onto glass fiber filters, and [3H]thymidine incorporation was measured in a liquid beta-scintillation counter. The results were expressed as counts per minute.
###end p 14
###begin title 15
Cytokine ELISA
###end title 15
###begin p 16
###xml 113 122 113 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 440 445 <span type="species:ncbi:10090">mouse</span>
###xml 535 540 <span type="species:ncbi:10090">mouse</span>
To analyze cytokine production, cells were cultured as described above; supernatant was collected after 72 hours in vitro antigen challenge. Concentrations of IFN-gamma in the supernatants were determined by the Cytoscreen Immunoassay Kit (BioSource, Camarillo, CA, USA) in accordance with the instructions of the manufacturer. In brief, the lymphocyte supernatant was added to an ELISA-plate coated with a monoclonal antibody specific for mouse IFN-gamma. After incubation and washing, a biotinylated polyclonal antibody specific for mouse IFN-gamma was added. Then streptavidin-peroxidase and later the substrate solution were added to detect the products of the reaction.
###end p 16
###begin title 17
Anti-CII antibody assay
###end title 17
###begin p 18
###xml 411 412 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 195 201 <span type="species:ncbi:9913">bovine</span>
###xml 347 352 <span type="species:ncbi:10090">mouse</span>
The serum from the mice was analyzed with ELISA for the quantification of IgG antibodies against CII. Micro-ELISA plates were coated overnight at 4degreesC with 50 mul of PBS containing 5 mug/ml bovine CII in each well. After washing, the sera were added and incubated at 37degreesC for 2 hours. After 1 hour of incubation at 37degreesC with anti-mouse-IgG conjugated with alkaline phosphatase (Pharmingen BD), p-nitrophenylphosphate containing substrate buffer (Sigma) was added, and 3 M NaOH was used to stop the reaction. The plates were read at 405 nm.
###end p 18
###begin title 19
Histopathology
###end title 19
###begin p 20
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were killed and paws were cut off and subsequently fixed in 4% paraformaldehyde solution. After decalcification for 2 to 3 weeks in an EDTA solution the paws were embedded in paraffin. The paws were sectioned and stained with H & E. Evaluation of disease was made according to a previously published scale [21]: 1, synovial hyperplasia; 2, start of pannus development; 3, erosions of bone and cartilage; 4, severe inflammation and erosions.
###end p 20
###begin title 21
Fluorescence-activated cell sorting analysis
###end title 21
###begin p 22
###xml 85 89 <span type="species:ncbi:10090">mice</span>
For the determination of T cell, B cell and NK cell populations in the different pfp-mice, lymphocytes were isolated and stained with fluorescein isothiocyanate (FITC)-labeled anti-CD4 antibody (Pharmingen; clone H129.19), phycoerythrin-labeled anti-CD8a antibody (Pharmingen; clone 43-6.7), FITC-labeled anti-CD45R/B220 antibody (Pharmingen; clone RA3-6B2), phycoerythrin-labeled anti-CD90 antibody (Pharmingen; clone OX-7), and anti-IgG-biotin and streptavidin-FITC before being analyzed by FACScan (Becton Dickinson; with Cell Quest software version 1.2.2).
###end p 22
###begin title 23
Statistics
###end title 23
###begin p 24
###xml 164 166 162 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 289 290 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 349 351 347 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Statistical evaluation was performed with SPSS software. For analyzing differences in clinical scores, a Mann-Whitney test was used. For incidence calculations, chi2 and Fisher tests were used. When analyzing differences in cytokine production and T cell proliferation, Student's unpaired t-test was used. Differences were considered significant at P < 0.05.
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Characterization of the pfp-deficient DBA/1J mice
###end title 26
###begin p 27
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 714 716 714 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1102 1106 1102 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1157 1175 1157 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional file 1a</xref>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 910 914 <span type="species:ncbi:10090">mice</span>
###xml 1106 1110 <span type="species:ncbi:10090">mice</span>
The pfp-deficient mice were originally derived from C57BL/6J strain by embryonic stem cell transfer. Because this strain is resistant to CIA induction, we backcrossed the mice for at least 14 generations into the CIA-susceptible DBA/1J background. The pfp gene is located on chromosome 10 at 36 cM, and the mutant gene was inherited as a C57BL/6J fragment of about 10 cM between about 28 and 39 cM (Table 1). To exclude the possibility that backcrossing with the DBA/1J strain revealed a defect in T cell, B cell or NK cell maturation we examined distribution of these different immune cell populations by fluorescence-activated cell sorting. It was found that T lymphocytes expressing CD4 and CD8, as well as CD90+ cells (CD90 is expressed on T cells and NK cells) and CD45R/B220-positive cells (B cells, activated killer cells) were present at comparable percentages in heterozygous and pfp-deficient DBA/1J mice, indicating that the lack of pfp did not affect development of these cell populations in the DBA/1J strain (data not shown). The lack of pfp expression in the activated T cells of the pfp-/- mice was confirmed at the RNA level by RT-PCR (see Additional file 1a).
###end p 27
###begin title 28
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Pfp-deficient mice are less susceptible to collagen-induced arthritis
###end title 28
###begin p 29
###xml 82 85 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 94 98 94 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 109 113 109 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 290 294 290 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 374 378 374 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 385 388 385 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 434 438 434 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 480 481 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 555 558 555 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 577 580 575 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 599 602 595 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 653 656 645 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 674 677 664 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 693 696 681 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 754 757 740 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 775 778 759 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 796 799 778 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 814 816 794 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 991 995 971 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1031 1035 1009 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1060 1061 1036 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1181 1185 1157 1161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1220 1223 1196 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1241 1244 1215 1218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 123 129 <span type="species:ncbi:9913">bovine</span>
###xml 137 140 <span type="species:ncbi:31658">CFA</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
###xml 349 353 <span type="species:ncbi:10090">Mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 905 910 <span type="species:ncbi:10090">mouse</span>
###xml 982 986 <span type="species:ncbi:10090">mice</span>
###xml 1035 1039 <span type="species:ncbi:10090">mice</span>
###xml 1185 1189 <span type="species:ncbi:10090">mice</span>
###xml 1198 1202 <span type="species:ncbi:10090">mice</span>
To investigate the role of pfp in collagen-induced arthritis, we immunized DBA-pfp-/-, DBA-pfp+/- and DBA-pfp+/+ mice with bovine CII in CFA. As shown in Fig. 1 and Table 2, mice deficient for pfp developed a less severe disease with lower clinical scores than mice with intact pfp. DBA-pfp-/- mice also showed a tendency to a delayed onset of CIA. Mice with intact pfp (pfp+/+ and pfp+/-) had an average incidence of 64%, whereas pfp-/- mice showed a mean incidence of 54% (Fig. 1). The severity of disease was decreased on day 50 after immunization (pfp-/-, 0.9 +/- 0.86; pfp+/-, 1.4 +/- 0.67; pfp+/+, 1.3 +/- 0.47 (means +/- SEM)), and on day 75 (pfp-/-, 2.1 +/- 1.7; pfp+/-, 3.8 +/- 1; pfp+/+, 5.2 +/- 1.2), and significantly decreased on day 82 (pfp-/-, 3.0 +/- 1.5; pfp+/-, 4.0 +/- 0.9; pfp+/+, 5.6 +/- 0.9; P < 0.05). Maxscore, calculated as the mean of the maximum score value for each individual mouse of a given genotype, was also significantly decreased in pfp-deficient mice (pfp-/- 3.4 +/- 1.45) in comparison with pfp+/+ mice (7.3 +/- 1.14; Fig. 1). In addition, the area under the curve, as a measure of severity, onset and chronicity, was significantly lower in pfp-/- mice than in mice carrying pfp (pfp-/-, 31.9 +/- 23; pfp+/-, 44.6 +/- 12.3).
###end p 29
###begin title 30
Histopathological features of CIA do not change with pfp deficiency
###end title 30
###begin p 31
###xml 65 69 65 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 76 80 76 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 185 189 185 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
To investigate joint histopathology, paws were dissected from pfp-/- and pfp+/- mice with CIA, H & E-stained and evaluated blind for signs of arthritis. Results (Fig. 2) reveal that pfp-/- mice can develop a severe arthritis with typical signs of CIA, namely proliferation of synoviocytes, infiltration of inflammatory cells, pannus development, and erosions of bone and cartilage. Comparing both genotypes, no differences in histopathological development of the disease were visible (Fig. 2).
###end p 31
###begin title 32
Lack of pfp does not affect the antibody response to collagen
###end title 32
###begin p 33
###xml 102 105 102 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 110 114 110 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 121 125 121 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 340 344 340 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 351 355 351 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 361 365 361 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
To investigate the role of pfp on the humoral immune response to collagen, sera were obtained from pfp-/-, pfp+/- and pfp+/+ mice at days 0 and 21 after immunization, and the levels of CII-specific IgG antibodies were measured by quantitative ELISA. No significant variations were seen in the levels of anti-CII-specific IgG between the pfp-/- and pfp+/- or pfp+/+ littermates (Fig. 3). Pfp-deficient mice showed a mean titer of anti-CII antibodies of 233 +/- 51.1, and the control group had a mean titer of anti-CII antibodies of 306 +/- 50.8 at day 21 after immunization. These data show that even without pfp the mice develop a strong humoral immune response against CII, suggesting that the lack of pfp does not affect the anti-CII antibody response.
###end p 33
###begin title 34
###xml 3 7 3 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
Pfp-/- mice mount an enhanced proliferative T cell response toward CII
###end title 34
###begin p 35
###xml 128 132 128 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 139 143 139 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 370 374 369 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 496 500 491 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 818 822 804 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 829 833 815 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 198 204 <span type="species:ncbi:9913">bovine</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 500 504 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
To investigate whether the T cell response against CII was affected by pfp deficiency, draining the lymph nodes of immunized pfp-/- and pfp+/+ was investigated for the proliferative response toward bovine CII. Perforin-deficient mice showed an enhanced T cell proliferation compared with pfp wild-type mice. As shown in Fig. 3, after stimulation with 0.1 mug/ml CII, pfp-/- mice showed a significantly elevated T cell proliferation of 12,835 +/- 2,750 cpm compared with 4,727 +/- 1,268 cpm in pfp+/+ mice; at a CII concentration of 1 mug/ml the T cell proliferation was also significantly increased in pfp-deficient mice (32,209 +/- 6,764 cpm) compared with pfp-wild-type mice (21,904 +/- 2,626 cpm). The IFN-gamma production of T cells from these mice was measured by ELISA, but no significant differences between pfp-/- and pfp+/+ mice were observed (data not shown).
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 117 121 117 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 920 922 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 605 610 <span type="species:ncbi:10090">mouse</span>
###xml 1352 1356 <span type="species:ncbi:10090">mice</span>
The primary aim of this study was to investigate whether the delayed onset and mild arthritis observed earlier in CD8-/- mice [19] is due to a lack of cytotoxic ability or a lack of some other aspects of T cell function such as the secretion of cytokines. Indeed, we found that pfp-deficient mice develop disease with reduced incidence, a slightly delayed onset, and significantly decreased severity, suggesting that CTL activity is important for the initiation and maintenance of arthritis in the CIA model. This is in agreement with earlier observations in the insulin-dependent diabetes mellitus (NOD) mouse model. In that model, as in CIA, pfp is a susceptible rather than a protective gene. This is in contrast to other disease models, for example experimental autoimmune encephalomyelitis (EAE), systemic lupus erythematosus (SLE) and autoimmune pancreatitis, in which pfp clearly protects against the disease [16-18,22]. The protective effects of pfp could be explained by its immune regulatory function, namely the killing of autoreactive B cells and functional self-lysis of activated T cells through AICD. Hence, its role in regulation of peripheral tolerance and its role in autoimmunity, which is distinct from, but overlaps, the role of the FasL/Fas and TNF/TNFR pathways, might be the reason for accelerated autoimmunity in pfp-deficient mice in the EAE and SLE models.
###end p 37
###begin p 38
###xml 379 383 379 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
In the present study we obtained evidence that pfp can also act as a susceptibility gene rather than a protective gene. A lack of the molecule led to reduced severity throughout the disease, a slightly delayed onset, and a reduced incidence of CIA. However, we also observed a strong anti-collagen B cell response with similar anti-collagen-specific IgG levels in control and pfp-/- mice, and significantly increased T cell proliferation in response to collagen. This might have been due to a reduced killing and accumulation of autoreactive T cells after activation because of impaired AICD. These findings indicate that a diminished adaptive response to collagen was not responsible for the reduced arthritis.
###end p 38
###begin p 39
###xml 79 81 79 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 145 147 145 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 671 673 667 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 706 708 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
Previous studies demonstrated a strong involvement of pfp in the control of CD8+ T cell homeostasis. Perforin deficiency resulted in enhanced CD8+ T cell expansion because of decreased killing of antigen-presenting cells and consequential prolonged stimulation by antigen [23,24]. Our results support these propositions: we observed a significantly increased T cell proliferation in pfp-deficient mice in comparison with controls. These data also suggest a role of pfp in the regulation of T cell homeostasis. Nevertheless, cytokines produced by cytotoxic T cells are also involved in the regulation of the T cell response. TNF-alpha, for example, can mediate AICD of CD8+ T cells through TNFR1 and TNFR2 [25].
###end p 39
###begin p 40
###xml 42 46 42 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 267 271 267 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 278 282 278 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 347 351 347 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 561 579 561 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional file 1b</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
The histopathology of CIA in wild-type pfp+/+ mice of the present study was similar to that seen in previous studies [26]. The data are therefore not shown again here. In the present study there were no significant differences between histopathological changes of pfp+/- and pfp-/- mice, most probably because of a severe disease in individual pfp-/- mice. This result argues for an additional involvement of pfp-independent death pathways in joint destruction. Indeed, pfp was upregulated in the inflamed arthritic joints of wild-type mice as shown by RT-PCR (Additional file 1b).
###end p 40
###begin p 41
###xml 148 157 148 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
This is similar to our recent finding showing that the FasL/Fas pathway has a proinflammatory role in CIA and an activating function on fibroblasts in vitro [27]. Fas-deficient mice developed arthritis that was less severe, probably through a reduced IL-1R1/Toll-like receptor-4 signaling that might contribute to a decreased expression of other cytokines, chemokines and matrix metalloproteinases potentially regulated by this pathway [28]. Previous studies also reported a strong involvement of the TNF/TNFR pathway because CIA only developed with a reduced disease incidence, and the severity and neutralization of TNF led to the prevention of arthritis [29,30].
###end p 41
###begin p 42
###xml 267 269 267 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 663 665 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 666 668 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
Taken together, the results show that in CIA the disease-promoting effect of pfp prevails. It is therefore tempting to speculate that pfp could contribute to arthritis in at least two ways. First, it could promote tissue damage by direct cytotoxic effects through CD8+ T cells and NK cells. Second, pfp might have some activating functions on fibroblasts or macrophages, leading to the production of proinflammatory cytokines. Indeed, there are reports indicating that fibroblasts and monocytes can be activated by granzyme A to secrete the proinflammatory cytokines IL-6, IL-8 and TNF-alpha, which could subsequently severely regulate the inflammatory response [31,32].
###end p 42
###begin p 43
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 701 706 701 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia8 </italic>
###xml 831 836 831 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia8 </italic>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1042 1044 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1109 1113 1109 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 356 364 <span type="species:ncbi:9606">patients</span>
###xml 1113 1117 <span type="species:ncbi:10090">mice</span>
There are other indications that argue for a prominent role of pfp in arthritis. Perforin was found to be differentially expressed in lymph nodes and joints of DBA/1J and FVB/N (CIA-resistant strain) mice (SM Ibrahim and D Koczan, unpublished observations) and pfp-expressing cytotoxic T lymphocytes and increased apoptosis were observed in the synovia of patients with rheumatoid arthritis [10,33,34]. The targeted pfp gene is likely to have a major role in the observed effects, on the basis of the absence of pfp production, although it is possible that other polymorphic genes in the linked region could also contribute to CIA reduction. Indeed, the pfp gene is mapped to a CIA-susceptible locus, Cia8 on chromosome 10. This quantitative trait locus is covered by the 12 cM C57BL/6J fragment including the mutant pfp gene. The Cia8 region contains several candidate genes that have been implicated in the modulation of CIA susceptibility, for example the macrophage migration inhibitory factor Mif [35] and the autoimmune regulator Aire [36]. However, the observation that heterozygous littermates and pfp+/+ mice that were also backcrossed and contained the same or smaller C57BL/6J fragments do not show effects on the disease argues against a major role for another gene.
###end p 43
###begin p 44
###xml 122 126 122 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
In summary, the CIA in pfp-deficient mice was mild and showed delayed onset and reduced incidence, but some individual pfp-/- mice also developed a severe disease. These results suggest that pfp-dependent cytotoxicity is involved in the initiation of tissue damage in arthritis, but that pfp-independent cytotoxic death pathways, for example the FasL/Fas pathway, might also contribute to CIA.
###end p 44
###begin title 45
Conclusion
###end title 45
###begin p 46
###xml 115 119 <span type="species:ncbi:10090">mice</span>
We report that arthritis developed only with reduced incidence, severity and delayed onset in pfp-deficient DBA/1J mice. These findings suggest that pfp-dependent cytotoxicity is involved in the initiation of tissue damage in arthritis but also that one or several other pfp-independent mechanisms, possibly involving FasL/Fas, contribute to the early phase of joint destruction in CIA.
###end p 46
###begin title 47
Abbreviations
###end title 47
###begin p 48
###xml 38 41 <span type="species:ncbi:31658">CFA</span>
AICD = activation-induced cell death; CFA = complete Freund's adjuvant; CIA = collagen-induced arthritis; CII = collagen type II; CTL = cytotoxic T lymphocyte; EAE = experimental autoimmune encephalomyelitis; ELISA = enzyme-linked immunosorbent assay; FITC = fluorescein isothiocyanate; H & E = hematoxylin and eosin; IFN = interferon; IL = interleukin; MHC = major histocompatibility complex; NK = natural killer; RT-PCR = reverse transcriptase polymerase chain reaction; pfp = perforin; SLE = systemic lupus erythematosus; TNF = tumor necrosis factor.
###end p 48
###begin title 49
Competing interests
###end title 49
###begin p 50
The author(s) declare that they have no competing interests.
###end p 50
###begin title 51
Authors' contributions
###end title 51
###begin p 52
KB, AK and HTR did the experimental work and contributed to writing the manuscript. KB and AK contributed equally to the work. DK, HJT, RH and SMI participated in the design and co-ordination of the study and drafted the manuscript. HJK and HN did the histopathology. EM carried out the T cell proliferation and cytokine assays. All authors read and approved the final manuscript.
###end p 52
###begin title 53
Supplementary Material
###end title 53
###begin title 54
Additional File 1
###end title 54
###begin p 55
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
A TIFF file showing the perforin mRNA expression level in CD8+ T cells of perforin-deficient, heterozygous and wild-type mice as well as the perforin mRNA expression level of healthy and inflamed joints from wild-type mice.
###end p 55
###begin p 56
Click here for file
###end p 56
###begin title 57
Acknowledgements
###end title 57
###begin p 58
We thank I Klamfuss, E Lorbeer and R Waterstradt for excellent technical assistance. This work was supported by grants from the DFG (DFG 243/1) and EU (EUROME) QL.
###end p 58
###begin article-title 59
Autoimmunity to type II collagen: an experimental model of arthritis
###end article-title 59
###begin article-title 60
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Immunisation against heterologous type II collagen induces arthritis in mice
###end article-title 60
###begin article-title 61
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II
###end article-title 61
###begin article-title 62
The genetic and immunopathological processes underlying collagen-induced arthritis
###end article-title 62
###begin article-title 63
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates
###end article-title 63
###begin article-title 64
###xml 15 21 <span type="species:ncbi:10090">murine</span>
Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma
###end article-title 64
###begin article-title 65
###xml 94 98 <span type="species:ncbi:10090">mice</span>
In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice
###end article-title 65
###begin article-title 66
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Interleukin-1 potentiates the development of collagen-induced arthritis in mice
###end article-title 66
###begin article-title 67
Effects of tumor necrosis factor alpha (TNF-alpha) on collagen arthritis
###end article-title 67
###begin article-title 68
Apoptosis in rheumatoid arthritis synovium
###end article-title 68
###begin article-title 69
Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes
###end article-title 69
###begin article-title 70
###xml 21 23 21 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Fas involvement in Ca2+-independent T cell-mediated cytotoxicity
###end article-title 70
###begin article-title 71
CTL granules: evolution of vesicles essential for combating virus infections
###end article-title 71
###begin article-title 72
###xml 52 57 <span type="species:ncbi:9606">human</span>
Identification of an astrocyte cell population from human brain that expresses perforin, a cytotoxic protein implicated in immune defense
###end article-title 72
###begin article-title 73
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
###end article-title 73
###begin article-title 74
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice
###end article-title 74
###begin article-title 75
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Perforin protects against autoimmunity in lupus-prone mice
###end article-title 75
###begin article-title 76
###xml 88 92 <span type="species:ncbi:10090">mice</span>
Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice
###end article-title 76
###begin article-title 77
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis
###end article-title 77
###begin article-title 78
###xml 10 16 <span type="species:ncbi:10090">murine</span>
Typing of murine major histocompatibility complex with a microsatellite in the class II Eb gene
###end article-title 78
###begin article-title 79
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies
###end article-title 79
###begin article-title 80
Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis
###end article-title 80
###begin article-title 81
Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma
###end article-title 81
###begin article-title 82
Perforin and Fas killing by CD8+ T cells limits their cytokine synthesis and proliferation
###end article-title 82
###begin article-title 83
Induction of apoptosis in mature T cells by tumour necrosis factor
###end article-title 83
###begin article-title 84
Gene-expression profile of collagen-induced arthritis
###end article-title 84
###begin article-title 85
###xml 44 48 <span type="species:ncbi:10090">mice</span>
A proinflammatory role for Fas in joints of mice with collagen-induced arthritis
###end article-title 85
###begin article-title 86
Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation
###end article-title 86
###begin article-title 87
Severe inflammatory arthritis and lymphadenopathy in the absence of TNF
###end article-title 87
###begin article-title 88
###xml 113 117 <span type="species:ncbi:10090">mice</span>
Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice
###end article-title 88
###begin article-title 89
###xml 28 33 <span type="species:ncbi:9606">human</span>
Extracellular activities of human granzymes. I. Granzyme A induces IL6 and IL8 production in fibroblast and epithelial cell lines
###end article-title 89
###begin article-title 90
###xml 28 33 <span type="species:ncbi:9606">human</span>
Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin
###end article-title 90
###begin article-title 91
Perforin and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis
###end article-title 91
###begin article-title 92
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Demonstration of granzyme A and perforin messenger RNA in the synovium of patients with rheumatoid arthritis
###end article-title 92
###begin article-title 93
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice
###end article-title 93
###begin article-title 94
Projection of an immunological self shadow within the thymus by the Aire protein
###end article-title 94
###begin title 95
Figures and Tables
###end title 95
###begin p 96
###xml 23 26 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 120 124 120 124 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 163 167 163 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 196 200 196 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 216 220 216 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 227 231 227 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 426 428 426 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
Perforin-deficient (pfp-/-) mice develop decreased collagen-induced arthritis (CIA). Percentage of CIA-affected animals (a) is decreased and average maximum score (b) is significantly lower in pfp-/- mice than in pfp+/- and pfp+/+ mice. Figures show results from two different experiments, with balanced groups, taken together. Maxscore was calculated as the mean maximum score for each individual mouse of a given genotype. *P < 0.05.
###end p 96
###begin p 97
###xml 40 44 40 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 66 70 66 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 76 80 76 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 94 98 94 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 152 156 152 156 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 214 218 214 218 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 319 323 319 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 329 331 329 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 343 347 343 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 353 355 353 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 178 183 <span type="species:ncbi:10090">mouse</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
Histopathology of perforin-deficient pfp-/- mice compared with pfp+/- mice. (a) Joint of a pfp-/- mouse with severe inflammation and erosions, stage 4. (b) Paw of a heterozygous mouse in the same stage of disease. (c) Comparison of histological and clinical evaluation of the disease. Data are values of severity of pfp+/- mice (n = 6) and pfp-/- mice (n = 6), and are shown as means +/- SEM.
###end p 97
###begin p 98
###xml 44 48 44 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 167 169 167 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 206 210 206 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 217 220 217 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 222 224 222 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 447 451 447 451 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 454 458 454 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 550 554 550 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 555 557 555 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 569 573 569 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 574 576 574 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 735 736 735 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 750 752 750 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 361 364 <span type="species:ncbi:31658">CFA</span>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 625 628 <span type="species:ncbi:31658">CFA</span>
Antibody response and T cell proliferation. (a) No significant variations in the levels of collagen-specific IgG antibodies between the perforin (pfp)-deficient mice (n = 6) and the control littermates (pfp+/- and pfp+/+; n = 10) were seen. Sera were obtained from the mice 21 days after immunization with collagen type II (CII) and complete Freund's adjuvant (CFA). Levels of collagen-specific IgG antibodies were measured by quantitative ELISA. (b) pfp-/- mice show an increased proliferation toward CII. Draining lymph nodes were obtained from pfp-/- (n = 3) and pfp+/+ (n = 3) mice 90 days after immunization with CII in CFA. The cells were cultured for 60 hours with collagen II in different concentrations, and then pulsed with [3H]thymidine. *P < 0.05.
###end p 98
###begin p 99
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Mapping of DBA perforin-deficient mice
###end p 99
###begin p 100
###xml 4 8 <span type="species:ncbi:10090">mice</span>
The mice were backcrossed for 14 generations to the DBA/1J background.
###end p 100
###begin p 101
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 85 89 85 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 96 100 96 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Summary of disease-related data of perforin-deficient (pfp-/-) mice compared with pfp+/- and pfp+/+ mice
###end p 101
###begin p 102
###xml 294 296 292 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 162 167 <span type="species:ncbi:10090">mouse</span>
Evaluations and analyses were performed as described in Materials and methods. Maxscore was calculated as the mean of the maximum score value for each individual mouse of a given genotype. Data are group mean values +/- SEM. Values with the same superscript letter are significantly different (P < 0.05). AUC, area under the curve.
###end p 102

